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PRE AND POST HSCT EVALUATION INDICATES REDUCTION OF PHYSICAL
AND FUNCTIONAL PERFORMANCE DUE TO TRANSPLANT
De Souza, C.V., Miranda, E.C.M., De Souza, C.A., Aranha, F.J.P.,
Vigorito, A.C. University of Campinas - UNICAMP, Campinas, S~ao
Paulo, Brazil
Introduction: Before, during and after hematopoietic stem cell
transplantation (HSCT) patients (pts) go throw significant physical,
psychological and psychosocial stress. This prospective study evalu-
ated physical and functional performance of pts pre and post HSCT
using a functional assessment.
Pts and Methods: From November 2008 to September 2010, 50
pts, median age 48 (18-67), 29 (58%) female, were enrolled in the
study. Data collection was performed pre and post autologous or al-
logeneic HSCT. The instruments were 2 minutes walking test
(2MWT), oxygen saturation (Sa02), heart rate (HR) and Borg Scale
(BS) before and after 2MWT for gate performance evaluation; Grip
Strength (GS) for hand strength evaluation, Schober Test (ST) for
spine mobility testing and maximum and adapted activity score
(MAS and AAS) of Human Activity Profile (HAP) questionnaire
for function role evaluation.
Results: 50 pts with hematological malignancies were evaluated pre
HSCT; 8 did not undergo HSCT; 3 died, 2 refused, 2 are in line and
1 was excluded. 42 out of 50 (84%) underwent HSCT, 21 allogeneic
and 21 autologous. 29 out of 42 (69%) pts performed both evalua-
tions; 13 pts did not perform both evaluations: 11 died prematurely
and 2 did not discharge until last analysis. Among groups who per-
formed both evaluations, we found significant lower values in the
2nd evaluation: 2MWT (p 5 0.007), GS for right and left hand (p
5 0.004 and 0.007), ST (p\ 0.0001), MAS and AAS (p\ 0.0001);
and higher values in HR (p5 0.02). Significant statistical differences
indicate decrease on aerobic conditioning at baseline and after phys-
ical stress, decline of function and gate performance, reduction of
muscle strength and spine flexibility and diminishing on function
role on daily activities post HSCT.
Conclusion:Our results suggest there were significant physical los-
ses in this population and that its intensity and specificity may guide
preventive measures and conduct a better rehabilitation program on
post HSCT period.
Support: FAPESP.242
EXECUTIVE FUNCTIONING IN PEDIATRIC STEM CELL TRANSPLANTA-
TION UTILIZING FMRI
Williams, S.E.1, Hill, R.1, Craveiro, L.2, Agarwal-Hashmi, R.2,
Weinberg, K.I.2, Reiss, A.L.1 1Stanford University School of Medicine,
Stanford, CA; 2Stanford University School of Medicine, Stanford, CA
Advances in the treatment of children undergoing stem cell trans-
plants (SCT) has led to greater rates of survival and a need for greater
understanding of cognitive late effects associated with that treat-
ment. The general clinical impression has been that heavily treated
leukemia patients who come to transplant with the burden of intra-
thecal chemotherapy to go under total body irradiation (TBI), with
or without cranial boost, in their preparative regimen may be at
a high risk of changes in their neuro-cognitive function post trans-
plant. This brief case-control investigation tested 18 children before
puberty. Eight post allogeneic bone marrow transplant recipients
(mean age10.79 years), who had received their transplant for leuke-
mia between 1995 and 2007, comprised the SCT group (See Table
1 for SCT group demographics). Ten typically developing children
(mean age11.00 years) comprised the control group of siblings (re-
gardless of age and gender) of the target group, to match as close
as possible factors such as environmental stimulation and genetic
role in intelligence and performance. All subjects were administered
the Wechsler Intelligence Scale for Children, 4th Edition and the
Wisconsin Card Sorting Task as part of a comprehensive neurocog-
nitive battery. Functional imaging was acquired for all subjects. A
behavioral task, NoGo/Go to employed to assess inhibitory func-
tioning. Results indicated no significant differences between the
SCT and control groups on performance of theNoGo/Go task. Spe-
cifically, there were no significant differences in accuracy in Nogo/
Go Hits (p 5 0.99), Nogo/Go D-prime (p 5 0.96), or Go-only
Hits (p 5 0.13). There were also no significant differences betweenthe groups with regard to response times in the Nogo/Go (p5 0.50)
or Go-only conditions (p 5 0.24). These findings indicate that the
networks that subserve executive functioning abilities, particularly
inhibitory control, are similar for children who undergo SCT, de-
spite of their treatments, and typically developing children. While
the sample size of this study is small and limits generalizability,
this study results were different than what was expected and substan-
tiates the utility of imaging technology to better understand the long
term cognitive functioning of patients who undergo SCT.Gender Diagnosis aGVHD cGVHDFemale: 4 ALL: 7 Yes: 4 Yes: 1Male: 4 AML: 1 No: 4 No: 7TBI with preparative
regimen for Tx.Cranial radiation
boost with Tx.Allogenic
graftProductYes: 8 Yes: 2 Full sibling
match: 5Bone
marrow: 8No: 0 No: 6 Unrelated: 3 Other: 0Pre Tx. Intrathecal
ChemotherapyYes: 8No:0243
BRONCHIOLITIS OBLITERANS SYNDROME AFTER HEMATOPOIETIC STEM
CELL TRANSPLANTATION: ANALYSIS OF SINGLE CENTER EXPERIENCE
Fujii, N., Hara, Y., Nishinohara, M., Kondo, E., Maeda, Y.,
Shinagawa, K., Tanimoto, M. Okayama University Hospital, Okayama,
Japan
Background: Bronchiolitis obliterans (BOS) after allogeneic stem
cell transplantation (allo-SCT) is a late-onset, life-threatening respi-
ratory complication that reduces patients’ quality of life. Although
some risk factors of BOS have been reported, most previous studies
were reported before 2000. Here, we retrospectively analyzed the in-
cidence of, and risk factors, for BOS among patients before 2010 to
determine whether a recent transplant procedure (e.g., cord blood or
non-myeloablative transplant) affects the incidence of BOS.
Patients and Methods: Between May 1995 and June 2010, 253 pa-
tients underwent allo-SCT for hematological malignancies at
Okayama University Hospital, and 162 who survived at least 100
days after allo-SCT (R-PBSCT, 70; UR-BMT, 57; and CBT, 35)
were evaluated in this study. Clinical diagnosis of BOS was deter-
mined using pulmonary function tests and typical changes on
high-resolution computed tomography.
Results:The incidence of BOSwas 5.5% (n5 9). Themedian age of
BOS patients was 41 years (range, 24-46) and the patient group com-
prised eight females and one male. The graft source was UR-BM in
one and R-PBSC in eight patients. No BOS was observed among
CBT recipients. Eight of nine BOS patients received a myeloablative
regimen and one BOS patient received a Flu-based non-myeloabla-
tive regimen. The median onset of BOS was 10 months (range, 3-45)
after transplant. Dry cough was the most common first symptom of
BOS. Four of nine BOS patients are still alive and the median sur-
vival after BOS was 32 months (range, 4-96). Univariate analysis re-
vealed that R-PBSCT, female gender, young age (\ 50 years),
myeloablative conditioning regimen, and extensive chronic GVHD
are risk factors for BOS.
Conclusions:Our results showed that the incidence of BOS in non-
myeloablative transplants was lower than in myeloablative trans-
plants. Although no BOS was observed among CBT recipients, the
difference was not significant compared with another graft source.244
OPTIMAL DURATION AND FREQUENCY OF IN-HOSPITAL LAY CARE-
PARTNER SUPPORT FOR POSITIVE IMPACT ON PATIENT SURVIVAL IN
ALLOGENEIC BMT
McLellan, L.1, Foster, L.W.2, Rybicki, L.1, Dabney, J.1, Cooper, M.1,
Bolwell, B.1 1Cleveland Clinic, Cleveland, OH; 2Cleveland State Univer-
sity, Cleveland, OH
S244 Poster Session IWe previously performed a retrospective study demonstrating
that a consistent lay care partner (CP) during the inpatient hospital
stay was associated with improved survival in allogeneic BMT. We
recently completed a follow up, prospective study which confirmed
that a CP was associated with improved survival. We additionally
captured data concerning coping techniques for the transplanted pa-
tients and their CPs. This analysis focuses on the optimal duration
and frequency of CP, as well as an analysis of coping skills and
outcomes.
For the purposes of this study, a lay care-partner (CP) was defined
as one person with the patient five or more days a week, beginning
upon admission. Allogeneic patients transplanted from 10/03 to
10/08 were asked to enroll in this study, and 164 of 213 enrolled.
Patients and CPs completed a Brief COPE (coping inventory) at
baseline, post-discharge, and 100 days post transplant.
88 patients (54%) had a CP. 68% of CPs were female, 60% were
a spouse, 30% were a parent, and 88% lived with the patient prior to
admission. CPs were with patients a median of 6.5 hours per day in-
hospital and median frequency of days with patient was 86% of inpa-
tient hospital days. Significantly better survival rates associated with
CP duration of. 3 hours per day in-hospital (P5 0.004) andCP fre-
quency of visits. 75% of inpatient days (P5 0.004). At 4 years post-
transplant, 42% of those with CPs are still alive versus 26% of
patients without CPs.
The data reveals that at baseline, there were statistically significant
correlations in coping between patient and CP on self-distraction (P
5 \ 0.001), use of emotional support (P 5 0.027), humor (P 5
0.017), religion (P 5\ 0.001), and self-blame (P 5 0.028). All of
the correlations were positive, indicating that as patient scores in-
crease CP scores also increased. Significant and positive correlations
were also found for venting (P 5 0.047) and acceptance (P 5 0.015)
at post-discharge, and for use of emotional support (P 5 0.029) and
use of instrumental support (P 5 0.042) at day 100 post-transplant.
Educating patients and CPs about the impact on survival of
optimal levels of CP support is important. Yet, BMT teammembers
are faced with counseling family members about the importance of
having an inpatient lay CP without provoking anxiety about respon-
sibility for patient survival. Providing a support program for CPs is
essential considering their vital contribution to patient outcomes
and their positive impact on patient coping.245
THE EXPERIENCE OF CAREGIVERS OF HEMATOLOGICAL CANCER
PATIENTS UNDERGOING A HEMATOPOIETIC STEM CELL TRANSPLANT:
A COMPREHENSIVE LITERATURE REVIEW
Beattie, S., Lebel, S. University of Ottawa, Ottawa, ON, Canada
Purpose: Although hematopoietic stem cell transplant (HSCT) has
become awell-established treatment formalignancies, it is a demand-
ing procedure with associated physical and psychological sequelae
that can affect patients and their family members. Caregivers to
HSCT patients not only have to cope with the life-threatening na-
ture of the disease and treatment, but they also have care-giving re-
sponsibilities. This study reviews the literature on the psychosocial
impact of being a caregiver to a HSCT patient.
Methods: A critical review of the literature published before June
2010 was conducted. Databases searched included CINAHL, Med-
line, PsycInfo, and Academic Search Complete, as well as a compre-
hensive reference review. Studies that pertained to caregivers of
children (under the age of 18) undergoing a HSCT or caregivers
to patients with non-hematological malignancies were excluded.
Fourteen original quantitative research articles and three qualitative
research articles were reviewed and analyzed.
Results: Caregiver distress is highest pre-transplant and decreases
over time, and caregivers display distress levels comparable to or
higher than patients’ reported distress levels. Predictors of caregiver
distress include gender, higher levels of subjective burden, and pa-
tient symptom distress. Caregivers reported uncertainty, fear of the
future, juggling patients’ needs with their own, and difficulties adapt-
ing to role changes; however, they also reported positive aspects to
care giving.
Conclusion:There are many limitations to the current research, in-
cluding small heterogeneous samples of caregivers and a lack of dy-
adic studies focusing on the reciprocal relationships between thepsychosocial functioning of the patient and caregiver. Future re-
search should be targeted towards unmet needs, identifying sub-
groups of caregivers who are more vulnerable to increased
distressed and poor psychosocial adaptation, and how the patient
and the caregiver reciprocally impact each other’s psychosocial ad-
justments over the transplant trajectory. Also, future research should
have direct clinical applications, by focusing on psychosocial inter-
ventions for HSCT caregivers, either with the patient or in a support
group format.246
ONCOFERTILITY: PRESERVING THE FUTURE FOR CHILDREN, ADOLES-
CENTS AND YOUNG ADULTS THROUGH PATIENT EDUCATION AND CLIN-
ICAL PRACTICE
Rosipal, N.C., Herrera Bell, D., Franklin, A.R.K. MD Anderson Cancer
Center, Children’s Cancer Hospital, Houston, TX
As advances in cancer treatment have led to improved survival
rates, the need to focus on quality of life has become evident. Every
year approximately 70,000 adolescents and young adults (AYA) aged
15-39 years and 10,000 children (\15 years) are diagnosed with can-
cer. The potential loss of fertility secondary to treatment has been
identified as a significant cause of distress in survivors. The risk of in-
fertility depends on multiple factors including the patient’s age, gen-
der, cancer diagnosis and treatment. For children and AYAs
undergoing stem cell transplantation, this risk is over 80%. Women
also have an increased risk of premature ovarian failure, which can
threaten bone and heart health. Survivorship literature reports
most patients do not recall a discussion about the potential loss of
fertility and available preservation options with their oncology
team. This information gap has led to the development of guidelines
by the American Society of Clinical Oncology (ASCO) advising that
the risk of infertility be explicitly discussed. AtMDAndersonCancer
Center, we have responded to this unmet need by implementing an
oncofertility consultation service. A pediatric oncologist and 2 nurse
practitioners with an interest in fertility see patients three half days
a week in the pediatric clinic. Our goals are to:
1) educate the patient about their unique infertility risk based on
Tanner staging and medical history
2) educate the patient about possible fertility preservation options,
3) educate female patients about the possibility of premature ovarian
failure and its implications regarding fertility, bone density and
heart disease,
4) refer patients to appropriate specialists for more specific counsel-
ing and or preservation procedures,
5) research the decision-making process involved in pursuit of fertil-
ity preservation
6) educate the institution and our colleagues on this topic
7) evaluate the impact of the service
Childhood and AYA cancer patients and their families must be
given opportunity to have an open discussion regarding the impact
cancer and its treatment may have on their future fertility as well
as current potential preservation options. We have developed
a consult service as an avenue to facilitate this information sharing
in a focused and open manner.LEUKEMIA
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PHILADELPHIA CHROMOSOME IS NOT AN ADVERSE PROGNOSTIC
FACTOR IN ACUTE LYMPHOBLASTIC LEUKEMIA AFTER MYELOABLATIVE
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Postow,M.1, Kim, H.T.2, Sun, L.2, Koreth, J.3, Armand, P.3, Cutler, C.3,
Alyea, E.P.3, Antin, J.H.3, Soiffer, R.J.3, Ho, V.T.3 1Memorial Sloan
Kettering Cancer Center, New York, NY; 2Dana-Farber Cancer Institute,
Boston, MA; 3Dana-Farber Cancer Institute, Boston, MA
Philadelphia chromosome positive (Ph1) acute lymphoblastic
leukemia (ALL) is associated with poor prognosis with conventional
chemotherapy. Whether Ph1 predicts poor prognosis after allo-
SCT is not well defined. We reviewed 157 adult patients with
ALL (Ph152; Ph- 5 105) who underwent myeloablative allo-SCT
